Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Study Design in Statistics01:15

Study Design in Statistics

8.2K
A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
8.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

129
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
129
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

220
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
220
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

146
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
146
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

195
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
195
Cancer Survival Analysis01:21

Cancer Survival Analysis

353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Biological aging and the incidence and progression of diabetic retinopathy and kidney disease in type 2 diabetes mellitus: A prospective cohort study.

Diabetes research and clinical practice·2026
Same author

Histone acetyltransferase Kat2a regulates glioma stem cell differentiation via Hsp90aa1-dependent oxidative phosphorylation.

Biochemical pharmacology·2026
Same author

Pannexin 1 attenuates hepatic steatosis and insulin resistance via AMPK-autophagy axis activation.

Cellular and molecular life sciences : CMLS·2026
Same author

Challenges and Strategies for Influenza Response After COVID-19 Pandemic.

Infectious diseases & immunity·2026
Same author

Liparis nervosa (Thunb.) Lindl.: A systematic review of botany, ethnopharmacology, phytochemistry, pharmacology, and clinical potentials.

Journal of ethnopharmacology·2026
Same author

Global Burden, Trends, and High-BMI-Attributable Risk of Hip Osteoarthritis: An Analysis of GBD 2021 Data.

International journal of rheumatic diseases·2026

相关实验视频

Updated: Jul 5, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

使用贝叶斯预测功率进行多个共同初级终点试验的无2/3相设计.

Jiaying Yang1, Guochun Li2, Dongqing Yang2

  • 1Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Rd, Nanjing, 210023, China. yang_jy@foxmail.com.

BMC medical research methodology
|January 17, 2024
PubMed
概括

使用贝叶斯预测能力 (BPP) 的新无2/3期临床试验设计提高了具有多个共同初级终点 (CPE) 的试验的效率. 与条件功率 (CP) 相比,这种方法提高了功率和早期停止徒劳的试验.

关键词:
贝叶斯的预测能力是贝叶斯的预测能力.同一初级终点的终点.有条件的功率功率.无的2/3阶段设计.

更多相关视频

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K

相关实验视频

Last Updated: Jul 5, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
00:04

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.3K
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

14.6K

科学领域:

  • 临床试验设计 临床试验设计
  • 生物统计学 生物统计学
  • 药学研究 药学研究

背景情况:

  • 无的2/3期临床试验越来越多地被采用,特别是单个终点研究.
  • 具有多个共同初级终点 (CPE) 的试验面临着膨胀的2型错误率和大样本大小的挑战.
  • 现有的方法在无设计中难以有效地管理多个CPE.

研究的目的:

  • 引入和评估使用贝叶斯预测能力 (BPP) 的新无二/三阶段设计策略.
  • 将BPP方法的性能与基于条件功率 (CP) 的方法对多个CPE进行比较.
  • 评估BPP对整体功率的影响,重新估计样本大小,并提前停止无用.

主要方法:

  • 开发了一个无的2/3阶段设计,结合贝叶斯预测功率 (BPP) 来进行临时徒劳性监测和样本大小重新估计.
  • 利用迪里克莱特多项式分布在多个共同初级终点 (CPE) 之间建模相关性.
  • 将BPP方法与基于条件功率 (CP) 的替代方法进行比较,使用模拟的无2/3期疫苗试验与四个二进制终点.

主要成果:

  • BPP方法的整体功率高于或与CP方法相比,特别是在较小的第二阶段样本大小 (例如50或100个受试者) 时.
  • 在n1=50和相关性r=0的情况下,BPP比CP显示出8.54%的功率优势.
  • 对于更大的第二阶段样本大小 (例如150或200),BPP在早期停止徒劳试验方面表现出更高的效率,与CP相比,在n1=200和 ρ=0.0时,早期停止概率的峰值差异为5.76%,n1=200和 ρ=0.0. 这两种方法都保持了1型错误率低于2.5%的水平.

结论:

  • 拟议的无2/3相设计将迪里克莱特多项式模型与贝叶斯预测功率 (BPP) 集成,提供了显著的优势.
  • 与CP方法相比,BPP为具有多个共同主终点的无设计终止徒劳试验提供了更好的功率和效率.
  • 这种基于BPP的策略是优化复杂场景中的临床试验设计的宝贵进步.